European Journal of Medical Research (May 2020)
The role of passive immunization in the age of SARS-CoV-2: an update
- Johannes C. Fischer,
- Kurt Zänker,
- Martijn van Griensven,
- Marion Schneider,
- Detlef Kindgen-Milles,
- Wolfram Trudo Knoefel,
- Artur Lichtenberg,
- Balint Tamaskovics,
- Freddy Joel Djiepmo-Njanang,
- Wilfried Budach,
- Stefanie Corradini,
- Ute Ganswindt,
- Dieter Häussinger,
- Torsten Feldt,
- Hubert Schelzig,
- Hans Bojar,
- Matthias Peiper,
- Edwin Bölke,
- Jan Haussmann,
- Christiane Matuschek
Affiliations
- Johannes C. Fischer
- Institute for Transplant Diagnostics and Cell Therapeutics, Heinrich Heine University
- Kurt Zänker
- The Nanjing Han & Zaenker Cancer Institute, Nanjing and Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing Tech University
- Martijn van Griensven
- MERLN Institute for Technology-Inspired Regenerative Medicine, Department cBITE, Maastricht University
- Marion Schneider
- Department of Experimental Anesthesiology, University of Ulm
- Detlef Kindgen-Milles
- Department of Anesthesiology and Intensive Care Medicine, Heinrich Heine University
- Wolfram Trudo Knoefel
- Department of Surgery, Heinrich Heine University
- Artur Lichtenberg
- Department of Cardiac Surgery, Heinrich Heine University
- Balint Tamaskovics
- Department of Radiation Oncology, Heinrich Heine University
- Freddy Joel Djiepmo-Njanang
- Department of Radiation Oncology, Heinrich Heine University
- Wilfried Budach
- Department of Radiation Oncology, Heinrich Heine University
- Stefanie Corradini
- Department of Radiation Oncology, University Hospital, LMU Munich
- Ute Ganswindt
- Department of Radiation Oncology
- Dieter Häussinger
- Clinic of Gastroenterology, Hepatology und Infectious Diseases, Heinrich Heine University
- Torsten Feldt
- Clinic of Gastroenterology, Hepatology und Infectious Diseases, Heinrich Heine University
- Hubert Schelzig
- Department of Vascular Surgery, Heinrich Heine University
- Hans Bojar
- NEXTGEN ONCOLOGY GROUP
- Matthias Peiper
- Heinrich-Heine-University
- Edwin Bölke
- Department of Radiation Oncology, Heinrich Heine University
- Jan Haussmann
- Department of Radiation Oncology, Heinrich Heine University
- Christiane Matuschek
- Department of Radiation Oncology, Heinrich Heine University
- DOI
- https://doi.org/10.1186/s40001-020-00414-5
- Journal volume & issue
-
Vol. 25,
no. 1
pp. 1 – 6
Abstract
Abstract The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.
Keywords
